Xiaofeng Lu

4.5k total citations
165 papers, 3.3k citations indexed

About

Xiaofeng Lu is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Xiaofeng Lu has authored 165 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 28 papers in Surgery and 28 papers in Immunology. Recurrent topics in Xiaofeng Lu's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Gastric Cancer Management and Outcomes (14 papers) and RNA Interference and Gene Delivery (10 papers). Xiaofeng Lu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Gastric Cancer Management and Outcomes (14 papers) and RNA Interference and Gene Delivery (10 papers). Xiaofeng Lu collaborates with scholars based in China, United States and United Kingdom. Xiaofeng Lu's co-authors include Hao Yang, Jingqiu Cheng, Lin Wan, Xinna Li, Dipika Gupta, Roman Dziarski, Huawei Cai, Shengfu Li, Haining Yu and Shengrong Shen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Xiaofeng Lu

157 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Lu China 32 1.4k 537 457 430 385 165 3.3k
Xu Yang China 31 1.2k 0.8× 395 0.7× 547 1.2× 555 1.3× 211 0.5× 151 3.0k
Yuhua Li China 31 1.3k 0.9× 739 1.4× 518 1.1× 757 1.8× 334 0.9× 148 3.1k
Rui M. Gil da Costa Portugal 27 999 0.7× 315 0.6× 509 1.1× 496 1.2× 159 0.4× 135 2.8k
Qinghua Yu China 32 2.0k 1.4× 596 1.1× 294 0.6× 471 1.1× 162 0.4× 160 3.9k
Xiao Chu China 31 983 0.7× 528 1.0× 302 0.7× 402 0.9× 338 0.9× 121 2.9k
Li Yang China 30 716 0.5× 329 0.6× 180 0.4× 314 0.7× 389 1.0× 164 2.9k
Rui Li China 32 1.3k 0.9× 326 0.6× 321 0.7× 225 0.5× 396 1.0× 180 3.5k
Jarosław Baran Poland 27 1.9k 1.4× 1.2k 2.2× 925 2.0× 467 1.1× 463 1.2× 110 4.0k
Silvya Stuchi Maria–Engler Brazil 32 1.1k 0.8× 285 0.5× 306 0.7× 355 0.8× 276 0.7× 124 2.8k
Lei Shi China 32 1.1k 0.8× 1.4k 2.7× 435 1.0× 196 0.5× 210 0.5× 122 4.0k

Countries citing papers authored by Xiaofeng Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Lu more than expected).

Fields of papers citing papers by Xiaofeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Lu. The network helps show where Xiaofeng Lu may publish in the future.

Co-authorship network of co-authors of Xiaofeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Lu. A scholar is included among the top collaborators of Xiaofeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Lu. Xiaofeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Li, Y. H. Zhan, Mufeng Li, et al.. (2025). 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer. Molecular Pharmaceutics. 22(3). 1633–1640. 2 indexed citations
2.
3.
Zhang, Qian, Guoqing Cao, Xiaolei Zhu, et al.. (2024). Deformation and failure analysis of laser-welded joints in bending I-core sandwich panels by finite element and digital image correlation. Ocean Engineering. 315. 119807–119807. 1 indexed citations
4.
Wang, Shimeng, Guan‐Yuan Chen, Chengyu Wu, et al.. (2024). RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities. Critical Reviews in Oncology/Hematology. 195. 104271–104271. 4 indexed citations
5.
Yu, Heng, Hang Jiang, Xiaofeng Lu, et al.. (2024). Analysis of risk factors for liver metastasis in patients with gastric cancer and construction of prediction model: A multicenter study. Discover Oncology. 15(1). 363–363.
6.
7.
Yu, Heng, et al.. (2023). Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors. Cancers. 15(2). 367–367. 11 indexed citations
8.
Lu, Xiaofeng, et al.. (2023). A feasible method to evaluate fetal palate: sequential sector-scan through oral fissure. BMC Pregnancy and Childbirth. 23(1). 157–157. 1 indexed citations
9.
Yang, Hao, et al.. (2022). A trimeric immunoglobin G‐binding domain outperforms recombinant protein G and protein L as a ligand for fragment antigen‐binding purification. Journal of Chromatography A. 1681. 463464–463464. 1 indexed citations
10.
Lv, Lin, et al.. (2022). DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation. Cancer Cell International. 22(1). 56–56. 26 indexed citations
11.
Chen, Kai, Feng Wang, Xiaofei Shen, et al.. (2021). Netting Gut Disease: Neutrophil Extracellular Trap in Intestinal Pathology. Oxidative Medicine and Cellular Longevity. 2021(1). 5541222–5541222. 17 indexed citations
12.
Liu, Xiaoli, Huan Zhang, Tingbin Zhang, et al.. (2021). Magnetic nanomaterials-mediated cancer diagnosis and therapy. PubMed. 4(1). 12005–12005. 23 indexed citations
13.
Fan, Jie, Yanru Feng, Ze Tao, et al.. (2021). A versatile platform for the tumor-targeted delivery of immune checkpoint-blocking immunoglobin G. Journal of Controlled Release. 340. 243–258. 6 indexed citations
14.
Zeng, De, Chunfa Chen, Shuming Sun, et al.. (2019). <p><em>Long noncoding RNA H19</em> is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma</p>. Cancer Management and Research. Volume 11. 2059–2072. 26 indexed citations
15.
Dong, Hua, Xiaofeng Lu, Jiachen Zi, & Xiaona Fan. (2019). Minor Sesquiterpenoid and Steroid Constitutes from Azadirachta indica A. Juss and Their Cytotoxic Activity. Journal of Pharmaceutical and Biomedical Sciences. 9(5). 1 indexed citations
16.
Fan, Qing, Ze Tao, Hao Yang, et al.. (2019). Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy. Journal of Controlled Release. 302. 63–78. 20 indexed citations
17.
Du, Shangce, Ji Miao, En Xu, et al.. (2018). NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death and Disease. 9(10). 948–948. 57 indexed citations
18.
Lu, Xiaofeng, D. N. Dai, Rongmin Yu, et al.. (2018). [Limonoids from seeds of Azadirachta indica and their cytotoxic activity].. PubMed. 43(3). 537–543. 2 indexed citations
19.
Yang, Hao, et al.. (2013). Penetratin-Mediated Delivery Enhances the Antitumor Activity of the Cationic Antimicrobial Peptide Magainin II. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 289–297. 39 indexed citations
20.
Wang, Min Hui, Shiyong Wang, Xinna Li, et al.. (2007). Human Peptidoglycan Recognition Proteins Require Zinc to Kill Both Gram-Positive and Gram-Negative Bacteria and Are Synergistic with Antibacterial Peptides. The Journal of Immunology. 178(5). 3116–3125. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu Yang Breakdown of academic impact, for papers by Yuhua Li Breakdown of academic impact, for papers by Rui M. Gil da Costa Breakdown of academic impact, for papers by Qinghua Yu Breakdown of academic impact, for papers by Xiao Chu Breakdown of academic impact, for papers by Li Yang Breakdown of academic impact, for papers by Rui Li Breakdown of academic impact, for papers by Jarosław Baran Breakdown of academic impact, for papers by Silvya Stuchi Maria–Engler Breakdown of academic impact, for papers by Lei Shi
Rankless by CCL
2026